Prions are infectious agents composed primarily, and apparently fundamentally, of misfolded protein rather than conventional genomes made of DNA or RNA. The word prion is derived from proteinaceous infectious particle and was introduced by Stanley Prusiner in the 1980s to describe the proposed infectious protein responsible for transmissible spongiform encephalopathies.
The defining molecular idea is that a normally folded host protein can exist in an alternative conformational state that is unusually stable, rich in beta sheet structure, resistant to many forms of degradation, and capable of promoting conversion of additional molecules of the same protein into the abnormal state. In mammals the best studied substrate is cellular prion protein, commonly abbreviated PrP, which is encoded by the PRNP gene and is normally associated with cell membranes, particularly in nervous tissue.
Disease associated with prions results when abnormal conformers accumulate, aggregate, interfere with cellular processes, and ultimately cause extensive neurodegeneration. Unlike viruses, bacteria and fungi, prions do not depend on an independent nucleic acid genome to encode their infectious information. Their unusual biology therefore challenges the conventional assumption that biological inheritance or infectious transmission must be based on nucleic acids. Prions are also distinguished from ordinary protein aggregates because experimentally transmissible prion states can propagate their structural information between compatible protein molecules.
The biology of prions is closely connected with conformational change and protein folding. Normal cellular prion protein is usually designated PrP superscript C, whereas the disease associated conformational state is often represented as PrP superscript Sc, although actual prion conformations are structurally heterogeneous and the classical terminology does not describe every molecular state. Conversion is thought to involve interaction between a susceptible normal protein and an abnormal conformer, followed by structural rearrangement and aggregation.
Different conformational states can produce distinct biological phenotypes even when the underlying amino acid sequence is identical, a phenomenon that has made prions an important example of protein based information storage. Aggregates may form oligomers, fibrils and larger deposits, and some evidence indicates that particular intermediate species can be especially damaging to cells. The central nervous system is particularly vulnerable because neurons have limited regenerative capacity and depend on highly regulated protein homeostasis.
Cellular systems involved in molecular chaperoning, autophagy, lysosomal degradation and the ubiquitin proteasome pathway can influence accumulation and toxicity. Prion propagation can therefore be understood as a pathological disturbance of protein quality control as well as an infectious process. The exact molecular pathway from initial conformational conversion to neuronal death is complex and remains an active area of research.
Prion diseases, collectively known as transmissible spongiform encephalopathies, include several naturally occurring or experimentally transmissible disorders affecting mammals. In humans they include Creutzfeldt Jakob disease, variant Creutzfeldt Jakob disease, kuru, fatal familial insomnia and Gerstmann Straussler Scheinker disease. Sporadic Creutzfeldt Jakob disease is the most common human prion disease and generally appears without an identifiable external exposure or inherited mutation. Familial forms are associated with pathogenic variants in PRNP, while acquired forms can result from particular transmission routes.
Kuru historically affected communities in Papua New Guinea and was associated with ritual mortuary practices involving consumption of infected tissue. Variant Creutzfeldt Jakob disease was linked epidemiologically to exposure to the bovine spongiform encephalopathy agent through contaminated food, although the mechanisms and historical exposure patterns are more complicated than a simple foodborne infection model. In animals, important examples include scrapie in sheep and goats, chronic wasting disease in cervids, and bovine spongiform encephalopathy in cattle. These disorders differ in host range, transmission patterns and epidemiology, but share the general feature of progressive neurodegeneration associated with abnormal prion protein. Clinical manifestations often include rapidly progressive neurological dysfunction, changes in coordination, cognition or behaviour, and ultimately severe neurological impairment.
A major feature of prion disease is its unusually long incubation period. Infection or initial molecular conversion may occur years or even decades before severe neurological symptoms become evident, depending on the disease, route of exposure, host genotype and other factors. Once symptoms become established, human prion diseases are generally progressive and fatal, and there is currently no established curative treatment capable of reliably eliminating the underlying infectious process.
Diagnosis commonly combines clinical assessment with specialised investigations such as electroencephalography, magnetic resonance imaging, cerebrospinal fluid biomarker testing and, where appropriate, molecular genetic analysis. Definitive confirmation may involve neuropathological examination and detection or characterisation of abnormal prion protein. Laboratory techniques have also been developed to amplify or detect disease associated prion conformations, including protein misfolding cyclic amplification and real time quaking induced conversion.
These methods exploit the ability of abnormal conformers to induce conversion of suitable substrate proteins and can substantially improve diagnostic sensitivity in appropriate settings. However, prion diagnosis remains technically demanding because symptoms can resemble other neurological disorders and because abnormal protein can be present in different tissues at different concentrations. Genetic testing is particularly relevant when a familial prion disorder is suspected, since pathogenic PRNP variants can substantially alter disease risk and inheritance patterns.
Prions are unusually resistant to many conventional methods of biological inactivation, which creates distinctive infection control requirements. Standard chemical disinfectants and routine sterilisation procedures that are effective against ordinary bacteria and viruses may not reliably eliminate prion infectivity. Medical instruments exposed to high risk tissues therefore require specialised decontamination procedures or, in particular circumstances, destruction rather than ordinary reuse. High risk tissues include central nervous system tissues and certain ocular tissues because abnormal prion protein can be concentrated there.
Environmental persistence is also important in diseases such as chronic wasting disease, where infectious material can enter soil and remain relevant to transmission ecology. Prion resistance does not mean that every form of environmental treatment is ineffective, but it does mean that validated procedures specifically designed for prion decontamination are required. Healthcare systems consequently maintain specialised protocols for suspected or confirmed cases. Tissue handling, surgical instrument management, pathology procedures and disposal of contaminated material are carefully controlled.
The unusual resistance of prions has also contributed to their importance in public health, veterinary disease surveillance and food safety. Because conventional microbial culture cannot be used to grow prions in the same manner as bacteria, investigation depends heavily on molecular, biochemical, animal and pathological approaches.
The genetics of the host strongly influences susceptibility to several prion diseases. Variation in PRNP can alter the probability of developing particular disorders, the age at which disease appears, the clinical phenotype and the efficiency with which particular prion strains propagate. A famous example is variation at codon 129 of human PRNP, where methionine and valine variants occur and can influence susceptibility and disease phenotype.
Prion strains are particularly interesting because distinct infectious phenotypes can arise without differences in a conventional nucleic acid genome. Instead, strain properties can reflect differences in the conformation, stability and aggregation behaviour of the misfolded protein. The concept of prion strains therefore extends the meaning of biological information beyond DNA sequence. Species barriers also influence transmission.
A prion adapted to one species may not efficiently convert the corresponding protein in another species, although changes in protein sequence, conformation, host genetics and exposure conditions can alter this barrier. Cross species transmission is therefore neither universally impossible nor automatically efficient. The relationship between sequence, conformation and host susceptibility is a central research problem in prion biology and has broader implications for understanding protein misfolding diseases.
Prions are often discussed alongside other protein misfolding disorders such as Alzheimer disease, Parkinson disease and Huntington disease, but these conditions should not automatically be classified as infectious prion diseases. Abnormal protein aggregation occurs in many neurodegenerative disorders, yet the presence of misfolded protein alone does not establish transmissibility between individuals.
Some proteins in noninfectious neurodegenerative diseases can display prion like templating behaviour within tissues, meaning that one abnormal molecule can influence the conformation of another, but this intracellular propagation is conceptually different from naturally transmissible prion disease. The distinction is important because the terms prion and prion like are sometimes used too broadly. Another misconception is that prions are simply toxic proteins with no biological specificity. In reality, their propagation depends on compatibility between conformational states and susceptible substrate proteins. Research into prions has consequently influenced wider understanding of protein folding, molecular chaperones, aggregation, neurodegeneration and biological information. Prion research has also contributed to experimental approaches for studying how structural states of proteins can encode heritable or transmissible phenotypes.
The broader significance of prions extends beyond their role as causes of rare neurological diseases. They provide an unusually clear demonstration that protein conformation can have biological consequences that are inherited through molecular templating rather than through changes in DNA sequence. Studies of prions have influenced fundamental questions concerning the definition of an infectious agent, the nature of biological information and the mechanisms by which proteins fold and misfold.
They also provide practical lessons in disease surveillance, veterinary epidemiology, infection control and diagnostic biotechnology. Chronic wasting disease illustrates how a prion disorder can have ecological dimensions because infected wildlife can shed infectious material and environmental contamination may influence transmission. Human prion diseases remain uncommon compared with many infectious diseases, but their severity, unusual incubation periods and resistance to conventional decontamination make them important in specialised medicine and public health.
Continuing research focuses on the molecular structures of infectious conformers, mechanisms of neurotoxicity, genetic susceptibility, improved early diagnosis, therapeutic strategies that block conversion or enhance clearance, and better understanding of environmental transmission. The field therefore connects molecular biology, structural biology, neuroscience, genetics, epidemiology and infectious disease science.
